Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China · Delayed Price · Currency is CNY 3.250
-0.060 (-1.81%)
Jun 11, 2026, 3:00 PM CST
SHA:600594 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,596 | 3,122 | 2,801 | 4,506 | 4,379 | 6,438 | |
Market Cap Growth | -10.54% | 11.44% | -37.83% | 2.89% | -31.98% | 55.75% |
Enterprise Value | 2,905 | 3,507 | 3,175 | 4,946 | 5,009 | 6,897 |
Last Close Price | 3.31 | 3.98 | 3.56 | 5.57 | 5.41 | 7.96 |
PE Ratio | - | - | - | 43.58 | - | 26.41 |
Forward PE | - | 19.12 | 19.12 | 19.12 | 19.12 | 19.12 |
PS Ratio | 1.51 | 1.68 | 1.29 | 1.60 | 1.60 | 1.92 |
PB Ratio | 1.16 | 1.38 | 1.08 | 1.49 | 1.37 | 1.81 |
P/TBV Ratio | 1.40 | 1.67 | 1.37 | 1.89 | 1.74 | 2.74 |
P/FCF Ratio | 10.05 | 14.08 | - | 18.23 | 195.73 | 13.24 |
P/OCF Ratio | 8.82 | 12.16 | 32.25 | 11.93 | 12.68 | 6.89 |
EV/Sales Ratio | 1.69 | 1.88 | 1.46 | 1.75 | 1.83 | 2.06 |
EV/EBITDA Ratio | - | 230.02 | - | 14.75 | 11.89 | 11.88 |
EV/EBIT Ratio | - | - | - | 34.40 | 20.08 | 15.92 |
EV/FCF Ratio | 11.24 | 15.82 | - | 20.01 | 223.87 | 14.18 |
Debt / Equity Ratio | 0.32 | 0.30 | 0.36 | 0.33 | 0.34 | 0.26 |
Debt / EBITDA Ratio | 92.25 | 30.25 | - | 2.88 | 2.52 | 1.56 |
Debt / FCF Ratio | 2.77 | 3.09 | - | 4.01 | 48.58 | 1.88 |
Net Debt / Equity Ratio | 0.10 | 0.10 | 0.16 | 0.10 | 0.16 | 0.15 |
Net Debt / EBITDA Ratio | 595.91 | 14.24 | -5.42 | 0.87 | 1.17 | 0.92 |
Net Debt / FCF Ratio | 0.87 | 0.98 | -43.08 | 1.19 | 22.11 | 1.10 |
Asset Turnover | 0.47 | 0.49 | 0.50 | 0.60 | 0.55 | 0.65 |
Inventory Turnover | 1.29 | 1.35 | 1.43 | 1.54 | 1.38 | 1.42 |
Quick Ratio | 1.01 | 0.96 | 1.15 | 1.56 | 1.17 | 1.03 |
Current Ratio | 1.70 | 1.59 | 1.84 | 2.23 | 1.74 | 1.59 |
Return on Equity (ROE) | -14.59% | -13.75% | -11.90% | 2.94% | -12.98% | 6.57% |
Return on Assets (ROA) | -2.68% | -2.46% | -3.72% | 1.90% | 3.14% | 5.26% |
Return on Invested Capital (ROIC) | -6.40% | -5.41% | -8.19% | 2.84% | 6.41% | 8.02% |
Return on Capital Employed (ROCE) | -6.20% | -5.90% | -8.20% | 3.90% | 6.70% | 10.90% |
Earnings Yield | -13.47% | -10.56% | -11.32% | 2.30% | -9.74% | 3.79% |
FCF Yield | 9.95% | 7.10% | -0.34% | 5.49% | 0.51% | 7.56% |
Dividend Yield | - | - | - | 1.19% | - | - |
Payout Ratio | - | - | - | 39.82% | - | 62.40% |
Buyback Yield / Dilution | 0.29% | 0.56% | 0.03% | 0.41% | -0.14% | 0.01% |
Total Shareholder Return | 0.29% | 0.56% | 0.03% | 1.59% | -0.14% | 0.01% |